| Age (year) [Mean (SD)] | 35.45 (8.08) |
| Disease Duration [Mean (SD)] | 7.63 (5.56) |
| Age of onset of disease [Mean (SD)] | 26.85(7.81) |
| Sex [n (%)] |
| Female | 474 (78.7) |
| Male | 128 (21.3) |
| Marital status [n (%)] |
| Single | 149 (24.8) |
| Married | 415 (68.9) |
| Divorced and widowed | 38 (6.3) |
| Education level [n (%)] |
| Secondary school or below | 145 (24) |
| high school | 214 (35.5) |
| University | 244 (40.5) |
| Job status [n (%)] |
| Employed | 128 (21.2) |
| Unemployed | 52 (8.6) |
| housewife | 378 (62.7) |
| Retired and disabled | 45 (7.5) |
| Current comorbid conditions [n (%)] |
| Diabetes | 7 (1.2) |
| Arthritis | 8 (1.3) |
| Hypertension | 17 (2.8) |
| Heart disease | 5 (0.8) |
| Thyroid disorders | 40 (6.6) |
| Migraine | 37 (6.1) |
| Asthma | 8 (1.3) |
| Inflammatory bowel disease | 9 (1.5) |
| kidney disease | 14 (2.3) |
| Liver disease | 4 (0.7) |
| infectious disorders | 2 (0.3) |
| Skin disorders | 2 (0.3) |
| Epilepsy | 11 (1.8) |
| Other disorders | 64 (10.6) |
| None | 375 (62.1) |
| EDSS Score [Mean (SD)] | 2.45 (2.11) |
| EDSS Class [n (%)] |
| Mild (1–3) | 432 (71.6) |
| Moderate (3.5–6.5) | 151 (25) |
| Severe (≥ 7) | 20 (3.4) |
| Course disease [n (%)] |
| Relapsing remitting | 459 (76.1) |
| Primary progressive | 19 (3.2) |
| Secondary progressive | 97 (16.1) |
| CIS | 28 (4.6) |
| MS medication [n (%)] |
| Interferon beta | 203 (33.7) |
| Glatiramer acetate | 47 (7.8) |
| Fingolimod | 114 (18.9) |
| Natalizumab injection | 41 (6.8) |
| Azathioprine | 20 (3.3) |
| Ritoximab injection | 97 (16.1) |
| Mitoxantrone | 1 (0.2) |
| Dimethilfumarat | 13 (2.2) |
| Trifulonumaide | 4 (0.7) |
| Mix (Azathioprine&Interferonbeta) | 24 (4) |
| Cyclophosmaide | 8 (1.3) |
| Metotruxat | 3 (0.5) |
| None | 28 (4.6) |
| Symptomatic treatment [n (%)] |
| Anti-depressant | 119(19.8) |
| Anticonvulsants | 111(18.4) |
| Anti-anxiety | 40(6.6) |
| Antipsychotic | 17(2.8) |
| Anticholinergic | 103(17.1) |
| anti-spasticity | 86(14.3) |
| Anti-fatigue | 56(9.3) |
| Beta blocker | 37(6.1) |
| Levothyroxine | 26(4.3) |
| anti-Anemia | 35(5.8) |
| Amantadine | 15(2.5) |
| supplements | 377(62.6) |
| Anti-lipid | 8(1.3) |
| NSAID | 10(1.7) |
| Alpha Adrenergic Inhibitor | 16(2.7) |
| Anti-acid | 39(6.5) |
| Modafinil | 8(1.3) |
